These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 36096339)

  • 1. Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins.
    Cogo S; Tomkins JE; Vavouraki N; Giusti V; Forcellato F; Franchin C; Tessari I; Arrigoni G; Cendron L; Manzoni C; Civiero L; Lewis PA; Greggio E
    Neurobiol Dis; 2022 Nov; 174():105858. PubMed ID: 36096339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction of spatacsin leads to axonal pathology in SPG11-linked hereditary spastic paraplegia.
    Pérez-Brangulí F; Mishra HK; Prots I; Havlicek S; Kohl Z; Saul D; Rummel C; Dorca-Arevalo J; Regensburger M; Graef D; Sock E; Blasi J; Groemer TW; Schlötzer-Schrehardt U; Winkler J; Winner B
    Hum Mol Genet; 2014 Sep; 23(18):4859-74. PubMed ID: 24794856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZFYVE26/SPASTIZIN and SPG11/SPATACSIN mutations in hereditary spastic paraplegia types AR-SPG15 and AR-SPG11 have different effects on autophagy and endocytosis.
    Vantaggiato C; Panzeri E; Castelli M; Citterio A; Arnoldi A; Santorelli FM; Liguori R; Scarlato M; Musumeci O; Toscano A; Clementi E; Bassi MT
    Autophagy; 2019 Jan; 15(1):34-57. PubMed ID: 30081747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia.
    Hehr U; Bauer P; Winner B; Schule R; Olmez A; Koehler W; Uyanik G; Engel A; Lenz D; Seibel A; Hehr A; Ploetz S; Gamez J; Rolfs A; Weis J; Ringer TM; Bonin M; Schuierer G; Marienhagen J; Bogdahn U; Weber BH; Topaloglu H; Schols L; Riess O; Winkler J
    Ann Neurol; 2007 Dec; 62(6):656-65. PubMed ID: 18067136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical heterogeneity and genotype-phenotype correlations in hereditary spastic paraplegia because of Spatacsin mutations (SPG11).
    Paisan-Ruiz C; Nath P; Wood NW; Singleton A; Houlden H
    Eur J Neurol; 2008 Oct; 15(10):1065-70. PubMed ID: 18717728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations c.[5121_5122insAG]+[6859C>T] of the SPG11 gene associated with cerebellum hypometabolism in a Chinese case of hereditary spastic paraplegia with thin corpus callosum.
    Ma J; Xiong L; Chang Y; Jing X; Huang W; Hu B; Shi X; Xu W; Wang Y; Li X
    Parkinsonism Relat Disord; 2014 Feb; 20(2):256-9. PubMed ID: 24315199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Janus-faced spatacsin (SPG11): involvement in neurodevelopment and multisystem neurodegeneration.
    Pozner T; Regensburger M; Engelhorn T; Winkler J; Winner B
    Brain; 2020 Aug; 143(8):2369-2379. PubMed ID: 32355960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPG11 mutations are common in familial cases of complicated hereditary spastic paraplegia.
    Paisan-Ruiz C; Dogu O; Yilmaz A; Houlden H; Singleton A
    Neurology; 2008 Apr; 70(16 Pt 2):1384-9. PubMed ID: 18337587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and phenotype of SPG11 and SPG15 in complicated hereditary spastic paraplegia.
    Schüle R; Schlipf N; Synofzik M; Klebe S; Klimpe S; Hehr U; Winner B; Lindig T; Dotzer A; Riess O; Winkler J; Schöls L; Bauer P
    J Neurol Neurosurg Psychiatry; 2009 Dec; 80(12):1402-4. PubMed ID: 19917823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPG11: a consistent clinical phenotype in a family with homozygous spatacsin truncating mutation.
    Del Bo R; Di Fonzo A; Ghezzi S; Locatelli F; Stevanin G; Costa A; Corti S; Bresolin N; Comi GP
    Neurogenetics; 2007 Nov; 8(4):301-5. PubMed ID: 17717710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum.
    Stevanin G; Santorelli FM; Azzedine H; Coutinho P; Chomilier J; Denora PS; Martin E; Ouvrard-Hernandez AM; Tessa A; Bouslam N; Lossos A; Charles P; Loureiro JL; Elleuch N; Confavreux C; Cruz VT; Ruberg M; Leguern E; Grid D; Tazir M; Fontaine B; Filla A; Bertini E; Durr A; Brice A
    Nat Genet; 2007 Mar; 39(3):366-72. PubMed ID: 17322883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new locus (SPG47) maps to 1p13.2-1p12 in an Arabic family with complicated autosomal recessive hereditary spastic paraplegia and thin corpus callosum.
    Blumkin L; Lerman-Sagie T; Lev D; Yosovich K; Leshinsky-Silver E
    J Neurol Sci; 2011 Jun; 305(1-2):67-70. PubMed ID: 21440262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel SPG11 mutations in Asian kindreds and disruption of spatacsin function in the zebrafish.
    Southgate L; Dafou D; Hoyle J; Li N; Kinning E; Critchley P; Németh AH; Talbot K; Bindu PS; Sinha S; Taly AB; Raghavendra S; Müller F; Maher ER; Trembath RC
    Neurogenetics; 2010 Oct; 11(4):379-89. PubMed ID: 20390432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the clinical spectrum of SPG11 gene mutations in recessive hereditary spastic paraplegia with thin corpus callosum.
    Abdel Aleem A; Abu-Shahba N; Swistun D; Silhavy J; Bielas SL; Sattar S; Gleeson JG; Zaki MS
    Eur J Med Genet; 2011; 54(1):82-5. PubMed ID: 20971220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal recessive hereditary spastic paraplegia with thin corpus callosum: a novel mutation in the SPG11 gene and further evidence for genetic heterogeneity.
    Pippucci T; Panza E; Pompilii E; Donadio V; Borreca A; Babalini C; Patrono C; Zuntini R; Kawarai T; Bernardi G; Liguori R; Romeo G; Montagna P; Orlacchio A; Seri M
    Eur J Neurol; 2009 Jan; 16(1):121-6. PubMed ID: 19087158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease.
    Montecchiani C; Pedace L; Lo Giudice T; Casella A; Mearini M; Gaudiello F; Pedroso JL; Terracciano C; Caltagirone C; Massa R; St George-Hyslop PH; Barsottini OG; Kawarai T; Orlacchio A
    Brain; 2016 Jan; 139(Pt 1):73-85. PubMed ID: 26556829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Compound Heterozygous Spatacsin Mutations in a Greek Kindred with Hereditary Spastic Paraplegia SPG11 and Dementia.
    Fraidakis MJ; Brunetti M; Blackstone C; Filippi M; Chiò A
    Neurodegener Dis; 2016; 16(5-6):373-81. PubMed ID: 27318863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel compound heterozygous mutations of the SPG11 gene in Korean families with hereditary spastic paraplegia with thin corpus callosum.
    Kim SM; Lee JS; Kim S; Kim HJ; Kim MH; Lee KM; Hong YH; Park KS; Sung JJ; Lee KW
    J Neurol; 2009 Oct; 256(10):1714-8. PubMed ID: 19513778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research on clinical and molecular genetics of hereditary spastic paraplegia 11 patients in China.
    DU J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1729-1732. PubMed ID: 36748384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point mutations and a large intragenic deletion in SPG11 in complicated spastic paraplegia without thin corpus callosum.
    Crimella C; Arnoldi A; Crippa F; Mostacciuolo ML; Boaretto F; Sironi M; D'Angelo MG; Manzoni S; Piccinini L; Turconi AC; Toscano A; Musumeci O; Benedetti S; Fazio R; Bresolin N; Daga A; Martinuzzi A; Bassi MT
    J Med Genet; 2009 May; 46(5):345-51. PubMed ID: 19196735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.